06 Nov miR-28 Inhibits Ibrutinib Resistance in B Cell Lymphomas Through the Regulation of Cellular Metabolism

Posted at 12:20h in INNOVATIVE THERAPIES by

ID: 03086

Authors: Álvarez-Corrales, Emigdio (1); Gómez-Escolar, Carmen (2); Moreno Palomares, Rocío (1); Fuertes Novella, Teresa (1,2); Laguna, María (1); Mur, Sonia (2); Martínez-Martín, Nuria (3); Somoza, Álvaro (4); R. Ramiro, Almudena (2); G. de Yébenes, Virginia (1)

Topic: INNOVATIVE THERAPIES